Cumberland Pharmaceuticals (CPIX) Non-Current Assets (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Non-Current Assets across 17 years of filings, most recently posting $38.2 million for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $38.2 million, changed 0.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $150.6 million (down 6.81% YoY), and the FY2025 annual result was $39.8 million, up 1.62% from the prior year.
• Non-Current Assets came in at $38.2 million for Q1 2026 at Cumberland Pharmaceuticals, down from $39.8 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $51.4 million in Q1 2022 to a low of $36.0 million in Q3 2025.
• The 5-year median for Non-Current Assets is $42.9 million (2024), against an average of $42.9 million.
• Across the five-year window, Non-Current Assets grew 21.36% in 2022 and decreased 15.99% in 2025, its largest moves.
• Cumberland Pharmaceuticals' Non-Current Assets stood at $47.1 million in 2022, then slipped by 2.11% to $46.1 million in 2023, then decreased by 15.05% to $39.1 million in 2024, then grew by 1.62% to $39.8 million in 2025, then declined by 3.92% to $38.2 million in 2026.
• The last three Non-Current Assets figures came in at $38.2 million (Q1 2026), $39.8 million (Q4 2025), and $36.0 million (Q3 2025), per Business Quant data.